Meridian's Q4, FY2010 Financial Results Disappoint

A weak flu season and competition in the C. difficile testing market cut into the firm's expected revenues.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories